Packed red blood cells: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
==General== | |||
*Type: | |||
*Dosage Forms: | |||
*Common Trade Names: | |||
==Adult Dosing== | |||
*One unit (250mL) raises hemoglobin by 1 g/dl | |||
**Usually transfuse at least 2 units at a time (15mL/kg in peds) | |||
*Must transfuse no slower than 1 unit/4hr | |||
**If require slower transfusion (e.g. risk for volume overload) the pRBC can be split | |||
==Pediatric Dosing== | |||
==Special Populations== | |||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | |||
*Lactation: | |||
*Renal Dosing | |||
**Adult | |||
**Pediatric | |||
*Hepatic Dosing | |||
**Adult | |||
**Pediatric | |||
==Features== | ==Features== | ||
*Can give type O Rh-positive pRBCs to a man or woman no longer of child-bearing age | *Can give type O Rh-positive pRBCs to a man or woman no longer of child-bearing age | ||
| Line 17: | Line 40: | ||
*Symptomatic anemia or cardiopulmonary disease AND Hb <10 | *Symptomatic anemia or cardiopulmonary disease AND Hb <10 | ||
== | ==Contraindications== | ||
* | *Allergy to class/drug | ||
** | |||
* | ==Adverse Reactions== | ||
* | ===Serious=== | ||
===Common=== | |||
==Pharmacology== | |||
*Half-life: | |||
*Metabolism: | |||
*Excretion: | |||
*Mechanism of Action: | |||
==See Also== | ==See Also== | ||
*[[Transfusions]] | *[[Transfusions]] | ||
== | ==References== | ||
<references/> | |||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Heme/Onc]] | [[Category:Heme/Onc]] | ||
Revision as of 17:39, 29 May 2015
General
- Type:
- Dosage Forms:
- Common Trade Names:
Adult Dosing
- One unit (250mL) raises hemoglobin by 1 g/dl
- Usually transfuse at least 2 units at a time (15mL/kg in peds)
- Must transfuse no slower than 1 unit/4hr
- If require slower transfusion (e.g. risk for volume overload) the pRBC can be split
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Features
- Can give type O Rh-positive pRBCs to a man or woman no longer of child-bearing age
- Options:
- Leukocyte reduced
- Eliminates 70-85% of leukocytes
- Reduces nonhemolytic febrile reactions
- Prevents sensitization in pts who may require bone marrow transplant
- Minimizes risk of HIV and CMV infection
- Irradiated
- Eliminates capacity of T-cells to proliferate (prevents graft-versus-host disease)
- Consider in transplant pts, neonates and immunocompromised patients
- Washed
- Indicated for pts w/ hypersensitivity to plasma (such as IgA deficiency)
- Leukocyte reduced
Indications
- Acute hemorrhage or chronic anemia with Hb <6
- Symptomatic anemia or cardiopulmonary disease AND Hb <10
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
